GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...
In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...
Nearly one million people in the U.S. are living with Parkinson's Disease. Playhouse Square is rolling out a new program to ...